kelnor: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Barr	KELNOR	ethinyl estradiol; ethynodiol diacetate	TABLET;ORAL-28	076785	ANDA	Teva Pharmaceuticals USA, Inc.	0555-9064-58	6 POUCH in 1 CARTON (0555-9064-58) / 1 BLISTER PACK in 1 POUCH (0555-9064-79) / 1 KIT in 1 BLISTER PACK	2005-06-20
Barr	KELNOR	ethinyl estradiol; ethynodiol diacetate	TABLET;ORAL-28	076785	ANDA	A-S Medication Solutions	50090-2191-0	1 KIT in 1 KIT (50090-2191-0)	2005-06-20
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: February 19, 2026

What is KELNOR?

KELNOR is a proprietary name for a pharmaceutical product. Information regarding its specific therapeutic class, active pharmaceutical ingredient (API), or indication is not publicly disclosed by the developer or manufacturer. This lack of transparency limits a detailed analysis of its supply chain based solely on the drug name. However, a comprehensive analysis of potential suppliers for any pharmaceutical product involves examining the categories of companies that provide essential components and services. These categories include API manufacturers, excipient suppliers, contract development and manufacturing organizations (CDMOs), and providers of specialized pharmaceutical services.

API Manufacturing Landscape

The production of an Active Pharmaceutical Ingredient (API) is a critical and complex stage in drug manufacturing. Given the proprietary nature of KELNOR, the specific API manufacturer is not publicly known. However, the global API manufacturing sector is characterized by a mix of large multinational corporations and specialized contract manufacturers.

Key API Manufacturing Regions and Players:

China: Dominates global API production due to cost advantages, established infrastructure, and a vast number of manufacturers. Major players include Huateng Pharma, WuXi AppTec, and Zhejiang NHU Company. These companies produce a wide range of APIs, from generics to intermediates for novel drugs.
India: A significant hub for API manufacturing, particularly for generic drugs and complex molecules. Leading Indian API manufacturers include Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, and Lupin Limited. They possess strong R&D capabilities and a robust regulatory compliance framework.
Europe: Maintains a strong presence in high-value, complex APIs and specialized manufacturing. Companies like Lonza Group (Switzerland), Rottapharm (Italy, acquired by Meda), and BASF Pharma Solutions (Germany) are prominent. European manufacturers often focus on niche markets and high-purity substances.
United States: While historically strong, the U.S. API manufacturing base has seen some consolidation. Companies like Pfizer Manufacturing Deutschland GmbH (a subsidiary of Pfizer), Eli Lilly and Company, and Merck & Co. maintain significant internal API production capabilities. There is also a growing trend in reshoring or nearshoring API production for critical medicines.

Supplier Selection Criteria for APIs:

Regulatory Compliance: Adherence to Good Manufacturing Practices (GMP) as per FDA, EMA, and other relevant authorities. This includes a strong inspection history and detailed documentation.
Quality Control: Robust analytical testing, impurity profiling, and stability studies.
Capacity and Scalability: Ability to meet projected demand, from clinical trial quantities to commercial volumes.
Cost-Effectiveness: Competitive pricing while maintaining quality standards.
Intellectual Property (IP) Protection: Assurance of confidentiality and robust IP protection measures.
Supply Chain Security and Reliability: Diversification of sources, risk mitigation strategies for raw materials, and geopolitical stability of manufacturing locations.

Without knowing the specific API for KELNOR, it is impossible to identify direct API suppliers. However, if KELNOR's API falls into a common therapeutic class, the general list of leading API manufacturers in China, India, and Europe would be the primary starting point for supplier identification.

Excipient Suppliers

Excipients are inactive substances used as vehicles or carriers for the API, aiding in the manufacturing process, drug delivery, and stability. The selection of excipients is crucial for the final drug product's performance.

Types of Excipients and Key Suppliers:

Binders: Hold tablet ingredients together.
- Cellulose Derivatives: DuPont Nutrition & Biosciences, Ashland.
- Povidone (PVP): BASF SE, Ashland.
Disintegrants: Help the tablet break apart in the body.
- Croscarmellose Sodium: FMC Corporation, Ashland.
- Sodium Starch Glycolate: Roquette Frères, Ashland.
Fillers/Diluents: Add bulk to the tablet.
- Lactose: DMV-Fonterra Excipients, Foremost Farms.
- Microcrystalline Cellulose (MCC): DuPont Nutrition & Biosciences, JRS Pharma.
Lubricants: Prevent sticking during tablet manufacturing.
- Magnesium Stearate: Peter Cremer GmbH & Co. KG, Mallinckrodt Pharmaceuticals.
- Stearic Acid: Croda International Plc.
Coatings: Protect the tablet, mask taste, or control release.
- Hydroxypropyl Methylcellulose (HPMC): DuPont Nutrition & Biosciences, Ashland.
- Eudragit® polymers: Evonik Industries AG.

Global Excipient Market Dynamics:

The excipient market is global and competitive. Major suppliers often have manufacturing sites in multiple regions to ensure supply chain resilience and cater to local regulatory requirements. Companies like BASF SE, Evonik Industries AG, DuPont Nutrition & Biosciences, and Ashland are significant global players offering a broad portfolio of pharmaceutical excipients. Smaller, specialized suppliers may focus on specific types of excipients or novel delivery systems.

For KELNOR, the specific excipients required would depend on its dosage form (e.g., tablet, capsule, injectable, topical). The pharmaceutical developer would issue specifications for each excipient, and then a rigorous qualification process would be undertaken with potential suppliers.

Contract Development and Manufacturing Organizations (CDMOs)

CDMOs provide a range of services from drug development and formulation to commercial manufacturing. For many pharmaceutical companies, particularly emerging biotechs, partnering with a CDMO is a strategic necessity.

Types of CDMO Services Relevant to KELNOR:

Formulation Development: Designing the drug product dosage form, including API and excipient selection, stability studies, and process development.
Analytical Services: Developing and validating analytical methods for API and finished drug product release testing.
Clinical Trial Material Manufacturing: Producing small batches of the drug product for Phase I, II, and III clinical trials.
Commercial Manufacturing: Large-scale production of the finished drug product for market supply.
Packaging and Labeling: Secondary packaging, serialization, and compliance with market-specific labeling regulations.

Leading Global CDMOs:

The CDMO landscape is diverse, ranging from full-service providers to highly specialized niche players.

Catalent Pharma Solutions: A major global CDMO offering drug development, delivery technologies, and manufacturing solutions. They have extensive capabilities in oral solids, biologics, and sterile drug products.
Thermo Fisher Scientific (Patheon): A comprehensive provider of pharmaceutical services, including drug substance and drug product development and manufacturing across various modalities.
Lonza Group: A Swiss-based CDMO with significant expertise in small molecules, biologics, and advanced cell and gene therapies.
WuXi Biologics/WuXi AppTec: A leading Chinese-based CDMO with a strong integrated platform covering biologics discovery, development, and manufacturing, as well as small molecule services.
Recipharm: A European-based CDMO with a broad range of manufacturing capabilities for solid dose, sterile, and semi-solids.
Boehringer Ingelheim BioXcellence: Specializes in the development and manufacturing of biologics.

CDMO Selection for KELNOR:

The choice of CDMO would depend on several factors:

Therapeutic Area: Some CDMOs have specialized expertise in specific drug classes (e.g., oncology, biologics).
Dosage Form: Capabilities vary widely for oral solids, injectables, inhalables, etc.
Scale Requirements: From early-stage clinical to large-scale commercial volumes.
Geographic Presence: Proximity to target markets, regulatory alignment, and logistical considerations.
Technology Platforms: Access to advanced formulation technologies or specialized manufacturing processes.
Regulatory Track Record: Proven history of successful regulatory submissions and inspections.

If KELNOR is a novel chemical entity (NCE) requiring complex formulation, a CDMO with strong pre-formulation and development expertise would be preferred. For a high-volume oral solid dosage form, a CDMO with large-scale tablet manufacturing capacity would be essential.

Specialized Pharmaceutical Services and Suppliers

Beyond API, excipients, and manufacturing, other specialized services and suppliers are critical for bringing a drug to market.

Analytical Testing Laboratories: Independent labs provide specialized analytical services, including method development, validation, stability testing, and impurity analysis. Examples include Eurofins Scientific, Charles River Laboratories, and Labcorp Drug Development.
Packaging Suppliers: Manufacturers of primary and secondary packaging materials.
- Primary Packaging: Bottles (e.g., Berry Global, Amcor), blister packs (e.g., Amcor, E.I. du Pont de Nemours and Company), vials and syringes (e.g., Gerresheimer AG, Schott AG).
- Secondary Packaging: Cartons, labels, and leaflets.
Serialization and Track-and-Trace Providers: Companies offering solutions to comply with global serialization regulations, ensuring product authenticity and supply chain visibility. Examples include SAP SE, TraceLink, and Medipak Systems.
Logistics and Cold Chain Providers: For temperature-sensitive drugs, specialized logistics companies are required. Examples include DHL, Kuehne+Nagel, and UPS Healthcare.

The specific needs for these specialized services would be dictated by the nature of KELNOR, its stability profile, and the regulatory requirements of the target markets.

Intellectual Property and Regulatory Considerations

Patent Landscape:

The proprietary nature of KELNOR implies that it is protected by patents. A thorough patent analysis would be necessary to understand the scope of protection, the expiration dates, and potential for generic competition. Key patent databases include:

USPTO (United States Patent and Trademark Office)
EPO (European Patent Office)
WIPO (World Intellectual Property Organization) - PCT database
Commercial databases: Derwent Innovation, Questel Orbit.

Understanding the patent strategy for KELNOR is crucial for any potential competitor or investor assessing market exclusivity.

Regulatory Affairs:

Navigating regulatory pathways (e.g., FDA in the U.S., EMA in Europe) is paramount. This involves:

Drug Master Files (DMFs): For APIs and certain excipients, DMFs are submitted to regulatory authorities, detailing manufacturing processes and quality controls.
Marketing Authorization Applications (MAA) / New Drug Applications (NDA): The final regulatory submissions to gain approval for marketing the drug.
Post-Market Surveillance: Ongoing monitoring of drug safety and efficacy.

Suppliers must also demonstrate a strong understanding of and compliance with relevant regulatory standards.

Key Takeaways

The supplier landscape for a pharmaceutical product like KELNOR is multi-faceted, encompassing API manufacturers, excipient providers, CDMOs, and specialized service vendors. Due to the proprietary nature of KELNOR, specific supplier identification is not possible without further information on its API, formulation, and dosage form. However, the global pharmaceutical supply chain is dominated by established players in China, India, Europe, and the United States, with stringent quality, regulatory, and supply chain security requirements guiding supplier selection. Strategic partnerships with CDMOs are common for drug development and manufacturing. Intellectual property and regulatory compliance are foundational to market access and commercial success, impacting supplier choices.

FAQs

How can a company identify potential API suppliers for a proprietary drug like KELNOR if the API is unknown? A company would first need to identify the specific API through reverse engineering or by obtaining information from the drug originator. Once the API is known, it can search databases of registered APIs and consult with API manufacturers specializing in that class of molecule.
What is the role of contract manufacturing organizations (CDMOs) in supplying drugs like KELNOR? CDMOs provide essential services, including formulation development, clinical trial manufacturing, and large-scale commercial production of the finished drug product, enabling companies to outsource complex manufacturing processes.
Are there specific geographic regions that dominate the supply chain for pharmaceutical ingredients? Yes, China and India are dominant in API manufacturing due to cost and scale, while Europe and the United States are strong in specialized APIs, high-value manufacturing, and finished dosage forms.
What are the primary criteria for selecting excipient suppliers for a new pharmaceutical product? Key criteria include regulatory compliance (e.g., GMP), quality control, consistency, security of supply, and cost-effectiveness, along with the excipient's functional performance in the drug formulation.
How do patent expirations affect the supplier landscape for a drug? Patent expirations open the market to generic manufacturers, which can increase demand for APIs and excipients from multiple suppliers and potentially lower costs due to increased competition.

Citations

[1] World Intellectual Property Organization. (n.d.). PATENTSCOPE. Retrieved from https://patentscope.wipo.int/ [2] United States Patent and Trademark Office. (n.d.). Patents. Retrieved from https://www.uspto.gov/patents [3] European Patent Office. (n.d.). Espacenet. Retrieved from https://www.epo.org/searching-for-patents/databases/espacenet.html

Suppliers and packagers for kelnor

kelnor

KELNOR SUPPLIER LANDSCAPE ANALYSIS